Metabolic Syndrome and Cardiovascular Risk Factors in Hypertensive Patients ≤ 65 years of Age
Keywords:
Metabolic syndrome, cardiovascular risk factors, hypertensive patientsAbstract
Background: Metabolic syndrome in hypertensive patients, it has been observed, during the long-term follow-up of patients with arterial hypertension (AHT), an increase in cardiac and cerebrovascular complications by 40% in those diagnosed with MS compared to those who did not have it.
Objective: To ascertain the metabolic syndrome prevalence in hypertensive patients with in the age of ≤65 years old and other cardiovascular risk and to examine its correlation with the level of blood pressure regulation.
Patients and method: A descriptive observational cross-sectional study was carried out in patients aged between 18 and 65 years, both inclusive, diagnosed with arterial hypertension previously, who granted their consent to participate in the study once informed of the objectives of the same. Those with physical, mental limitation or concurrent illness that made it impossible to answer the questionnaire were excluded, as well as those who refused participation once informed of the objectives of the study.
Results: The mean age of the participants was 57.6 years (SD: 6.5), with an age range between 37 and 65 years. The characteristics of the participants according to sex, although there were no statistically significant differences (42.5% in males and 38.05% in females). Considering the 2001 ATP III and IDF definitions, 38.2% (95% CI: 32.2%-44.21%) and 42.7% (95% CI: 36.6%-48.8%) met metabolic syndrome criteria, respectively
Conclusion: The current study show that 40.4% of the hypertensive patients were suffer from metabolic syndrome, regardless of the criteria used, and more than two thirds have abdominal obesity, Furthermore, we determined that metabolic syndrome is not merely a modifier of cardiovascular risk but should also be regarded in the management of blood pressure in hypertensive individuals, alongside therapeutic adherence, comorbidities, and physical activity
Downloads
References
Mulè G, Calcaterra I, Nardi E, Cerasola G, Cottone S. Metabolic syndrome in hypertensive patients: an unholy alliance. World journal of cardiology. 2014 Sep 26;6(9):890.
Aldiab A, Shubair MM, Al-Zahrani JM, Aldossari KK, Al-Ghamdi S, Househ M, Razzak HA, El-Metwally A, Jradi H. Prevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi Arabia. BMC public health. 2018 Dec;18:1-9.
Redon J, Martinez F, Pichler G. The metabolic syndrome in hypertension. InManual of Hypertension of the European Society of Hypertension, Third Edition 2019 Jun 6 (pp. 135-147). CRC Press.
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5· 4 million participants. The Lancet. 2011 Feb 12;377(9765):568-77.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31 (7): 1281-357.
Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008 Jun 10;117(23):3031-8.
Eduard MS, Julio PF, Alejandra RF. Co-Occurrence of cardiometabolic disease risk factors: Unhealthy eating, tobacco, alcohol, sedentary lifestyle and socioeconomic aspects. Arquivos Brasileiros de Cardiologia. 2019 Oct;113(4):710-1.
Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G, Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European society of hypertension position statement. Journal of hypertension. 2008 Oct 1;26(10):1891-900.
Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category “pre-hypertension” in a Japanese population. Curr Med Res Opin. 2004; 20 (9): 1365-70.
Grundy SM, Brewer BH Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109 (3): 433-8.
de la Fuente GD, Tocora DG, Sevillano BH, del Valle KP. Protocol diagnosis and treatment of hypertension in metabolic syndrome and type 2 diabetes mellitus. Medicine-Accredited Continuing Medical Education Program. 2019 Jun 1;12(81):4800-3.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285 (19): 2486-97.
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14 (3): 173-94.
Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005; 165 (22): 2644-50.
Fernández-Bergés D, Cabrera de León A, Sanz H, Elosua R, Guembe MJ, Alzamora M, et al. Síndrome metabólico en España: prevalencia y riesgo coronario asociado a la definición armonizada y a la propuesta por la OMS. Estudio DARIOS. Rev Esp Cardiol. 2012; 65 (3): 241-8.
Calbo JM, Terrancle I, Fernández P, Rodríguez MJ, Martínez V, Santisteban Y, et al. Prevalencia del síndrome metabólico en la provincia de Albacete. Rev Clin Esp. 2007; 207 (2): 64-8.
Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010; 2 (10): 180-93.
De la Sierra A, Romero R, Bonet J, Pérez M, López JS, Ravella R, et al. Prevalencia y características del síndrome metabólico en la población hipertensa española. Med Clin (Barc). 2006; 126 (11): 406-9.
Rodilla E, García L, Merino C, Costa JA, González C, Pas¬cual JM. Importancia del síndrome metabólico en el control de la presión arterial y de la dislipemia. Med Clin (Barc). 2004; 123 (16): 601-5.
De la Sierra A, Alegría E, Martínez-Castelao A, Morillas C, González-Segura D. Características de los pacientes con hipertensión y síndrome metabólico atendidos por diferentes especialistas. Med Clin (Barc). 2012; 138 (4): 145-50.
